Analyst Recommendations

52.02 0.72(1.40%)07/03/2024
Halozyme Therapeutics Inc. (HALO)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Buy15
Market Outperform3
Neutral2
Overweight1

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades